Multiple Myeloma (Relapsed) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Multiple Myeloma (Relapsed)
Multiple myeloma is a cancer that begins in the plasma cells, a type of white blood cell found in the bone marrow. These cancerous plasma cells can crowd out healthy blood cells, weaken bones, and impact kidney function. While initial treatments often lead to remission, for many, the disease eventually returns. This is known as relapsed multiple myeloma.
When multiple myeloma relapses, it means the cancer has re-emerged after a period of improvement or remission following prior treatment. This can be a difficult time, as patients and their care teams must evaluate new strategies. The goals of treating relapsed multiple myeloma typically focus on controlling the disease, improving quality of life, and extending survival.
Treatment approaches for relapsed multiple myeloma are highly individualized, depending on factors like prior treatments, duration of remission, disease aggressiveness, and the patient's overall health. Common medications and treatment types include:
- Proteasome Inhibitors: Drugs like carfilzomib, bortezomib, and ixazomib work by blocking enzymes essential for cancer cell survival.
- Immunomodulatory Drugs (IMiDs): Medications such as lenalidomide and pomalidomide modify the immune system to fight cancer cells.
- Monoclonal Antibodies: Targeted therapies like daratumumab and isatuximab attach to specific proteins on myeloma cells, marking them for destruction by the immune system.
- Chemotherapy and Steroids: These can be used alone or in combination with other drugs.
- New
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.